Ignore This Picture
Spacer
faculty photo

Doris A. Stoffers, M.D., Ph.D

Associate Professor of Medicine
Member
Member
Member
Director
Member
Department: Medicine

Contact information
726 Clinical Research Building (office)
725/720 Clinical Research Building (lab)
415 Curie Boulevard
Philadelphia, PA 19104-6145
Office: 215 573-5413
Fax: 215 898-5408
Education
B.A. (Chemistry)
Johns Hopkins University , 1984.
M.D.
Johns Hopkins University, School of Medicine, 1991.
Ph.D. (Neuroscience)
Johns Hopkins University, School of Medicine, 1991.
Post-Graduate Training
Intern in Medicine, Brigham and Women's Hospital, Boston, MA, 1991-1992.
Resident in Medicine, Brigham and Women's Hospital, Boston, MA, 1992-1993.
Fellowship in Endocrinology, Massachusetts General Hospital, Boston, MA, 1993-1996.
Postdoctoral Research Fellowship, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 1994-1998.
Burroughs Welcome Biomedical Research Fellow, Bunting Institute, Radcliffe College, Harvard University, 1995-1996.
Certifications
American Board of Internal Medicine (General Internal Medicine), 1994.
American Board of Internal Medicine (Endocrinology, Diabetes and Metabolism). Recertified 2005-2015 , 1995.
Permanent link
 
> School of Medicine   > Faculty   > Details

Description of Research Expertise

Research Interests
- transcription factors and signal transduction
- embryonic development and adult regeneration of the endocrine pancreas
- relationship of defects in these pathways to the pathophysiology of diabetes mellitus, a disease caused by a deficiency in the production or action of insulin

Key words: Diabetes, insulin, beta cell, pancreas development, transcriptional regulation, signal transduction.

Description of Research
Research in our laboratory focuses on the embryonic development and adult regeneration of the endocrine pancreas, and the relationship of defects in these pathways to the pathophysiology of diabetes mellitus, a disease caused by a deficiency in the production or action of insulin. The beta cells of the endocrine pancreas are the only source of insulin production in the body- therefore the regulation of beta cell mass is pivotal to the development of diabetes and successful therapies aimed at correcting diabetes must impact beta cell growth and/or function. Further support for this focus derives from genetic studies linking monogenic forms of human diabetes to mutations in transcription factors that regulate the development of beta cell mass. A model example is the homeobox transcription factor, IPF-1/PDX-1, that plays critical roles in embryonic pancreas development and in differentiated islet beta cell function in the adult endocrine pancreas. Using cutting edge molecular methods, yeast two hybrid libraries, transgenic and knock-out mice, cDNA microarray, chromatin immunoprecipitation, human genetics, and genomic and proteomic approaches, our current projects include:

1. Characterization of a novel PDX C-terminus Interacting Factor, PCIF1, identified in a yeast two-hybrid screen. PCIF1 is a novel nuclear factor that recruits Pdx1 into a cullin3 based E3 ubiquitin ligase for polyubiquitination and proteasomal degradation. Biochemical, molecular, in vivo and human genetics approaches are being applied to elucidate the role of this novel regulatory molecule.
2. Examining the molecular mechanisms by which the incretin hormone GLP-1 stimulates expansion of beta cell mass, with a particular emphasis on signal transduction and the identification of molecular mechanisms whereby GLP-1 promotes beta cell regeneration and regulates PDX expression.
3. Elucidating molecular mechanisms underlying islet compensation for diet-induced insulin resistance.
4. Identifing targets of Pdx1, Pbx and Meis homeodomain factors in the pancreatic ß cell.

Rotation Projects for 2007-2008
Lab rotation projects are available in all of the major areas described above. Please arrange for an appointment to discuss.

Lab personnel:
Doris A. Stoffers, MD, PhD, Principal Investigator
Jiangying Liu, PhD Postdoctoral Fellow
Ada Po Man Suen, PhD Postdoctoral Fellow
Scott Soleimanpour, MD, Postdoctoral Fellow
You Wang, Postdoctoral Fellow
Jennifer Oliver-Krasinski, Graduate Student
Mira Sachdeva, Graduate Student
Katy Claiborn, Graduate Student
Cynthia Khoo, Graduate Student
David Groff, Research Specialist
Juxiang Yang, PhD, Research Specialist

Selected Publications

De Leon DD, Farzad CF, Crutchlow MF, Brestelli J, Tobias J, Kaestner KH, and Stoffers DA : Identification of Transcriptional Targets During Pancreatic Growth after Partial Pancreatectomy and Exendin-4 Treatment Physiological Genomics 24(2): 133-43, Jan 2006.

Lee CS, De Leon DD, Kaestner KH and Stoffers DA: Regeneration of pancreatic islets after partial pancreatectomy does not involve the reactivation of neurogenin3. Diabetes 55(2): 269-72, Feb 2006.

Means AL, Meszoely IM, Suzuki K, Miyamoto Y, Rustgi AK, Coffey RJ Jr, Wright CVE, Stoffers DA, Leach SD: Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132(16): 3767-76, Aug 2005.

Liu AH, Desai BM and Stoffers DA: Structure-function analysis and developmental expression of PCIF1, a novel PDX-1 C terminus interacting factor. Keystone Symposium, "Diabetes Mellitus: Molecular Mechanisms, Genetics and New Therapies", Keystone, CO 2005.

Stoffers DA, Liu AH, Desai BM, Sachdeva M, Oliver-Krasinski J, Claiborn K: Maturity Onset Diabetes of the Young (MODY): Human monogenic diabetes and unraveling genetic transcriptional networks of the beta cell. Proceedings of Keystone Symposium "Diabetes Mellitus: Molecular Mechanisms, Genetics and New Therapies", Keystone, CO 2005 Notes: Symposium presentation.

Desai BM, Farzad C, De Leon DD, Guoping S, Leach SD, Stoffers DA: Mature Pancreatic Acinar Cells Do Not Transdifferentiate into Islet Endocrine Cells after Partial Pancreatectomy In Vivo 65th Annual Scientific Sessions of the American Diabetes Association (228-OR), 2005 Notes: Oral Presentation.

Crutchlow MF, Deng S, Yu M, Bae Y-S, Stoffers DA : Exendin-4 Prolongs Mouse Islet Allograft Function, Promotes Hypoglycemia in the Early Post Transplant Period 65th Annual Scientific Sessions of the American Diabetes Association (100-OR), 2005 Notes: Oral presentation.

Ham JN , Crutchlow MF , Desai BM , Simmons RA, Stoffers DA: Neonatal Exendin-4 administration normalizes islet vascularity in the rat intrauterine growth retardation model: potential role of VEGF. Annual Meeting of the Endocrine Society (PI-9), 2005.

Oliver-Krasinski J, Meinkoth JL, Stoffers DA: Rap1 Is Not Required For Erk Activation By The GLP-1 Receptor Pathway In Ins-1 832/13 Cells. 65th Annual Scientific Sessions of the American Diabetes Association (1759-P ), 2005.

Liu AH, Desai BM, Stoffers DA : Developmental Expression and Structure-Function Regulation of PCIF1, a PDX1 Coregulator. 65th Annual Scientific Sessions of the American Diabetes Association (1674-P), 2005.

back to top
Last updated: 10/09/2008
The Trustees of the University of Pennsylvania
 
Spacer

[Return to members list]

Spacer